In comments submitted to the FDA, NPC outlined ways to improve how the exchange of clinical and economic information between biopharmaceutical manufacturers, payers, and population-health decision makers is regulated.

Health plans collect huge amounts of data through electronic health records, administrative claims, mobile health devices and other sources. This white paper explores whether the data simply sits on a shelf, or is used to shape care delivery, improve system efficiency, and achieve better health outcomes.

Dr. Alan Balch and the National Patient Advocate Foundation focus not only on the quality of a patient’s treatment paradigm, but also on what matters most to patients and how those factors inform their care and quality of life. Dr. Balch shared his thoughts about the impact of quality measures on patient care, particularly in the oncology space.